Bone Metabolism in Thalassemia^a

This publication has 15 references indexed in Scilit:

• Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with β‐thalassaemia
  European Journal of Haematology, 1997
• Results of Long-Term Iron-Chelating Therapy
  Acta Haematologica, 1996
• Effects of deferoximine on chondrocyte alkaline phosphatase activity: Proxidant role of deferoximine in thalassemia
  Calcified Tissue International, 1995
• Urinary pyridinoline and deoxypyridinoline in healthy children and in children with growth hormone deficiency
  Journal of Clinical Endocrinology & Metabolism, 1995
• The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches
  Clinical Endocrinology, 1995
• Growth patterns in patients with thalassaemia major
  Acta Paediatrica, 1994
• Deferoxamine-induced bone dysplasia in patients with thalassemia major.
  American Journal of Roentgenology, 1991
• Measurement of Bone Mineral Content of the Lumbar Spine by Dual Energy X-Ray Absorptiometry in Normal Children: Correlations with Growth Parameters
  Journal of Clinical Endocrinology & Metabolism, 1990
• Osteoporosis in Hemochromatosis: Iron Excess, Gonadal Deficiency, or Other Factors?
  Annals of Internal Medicine, 1989
• Calcium Phosphate Metabolism and Bone Disease in Patients with Homozygous Thalassemia
  Journal of Clinical Endocrinology & Metabolism, 1982